View in EDS

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.

Saved in:
Bibliographic Details
Title: SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Authors: Peluso, Michael J.1 michael.peluso@ucsf.edu, Saki Takahashi1, Hakim, Jill1, Kelly, J. Daniel2, Torres, Leonel1,3, Iyer, Nikita S.3, Turcios, Keirstinne1, Janson, Owen1, Munter, Sadie E.3, Thanh, Cassandra3, Donatelli, Joanna3, Nixon, Christopher C.3, Hoh, Rebecca1, Tai, Viva1, Fehrman, Emily A.1, Hernandez, Yanel1, Spinelli, Matthew A.1, Gandhi, Monica1, Palafox, Mary-Ann4, Vallari, Ana4
Source: Science Advances. 7/28/2021, Vol. 7 Issue 31, p1-12. 12p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first